ResearcherServicio Gallego de SaludActive in the last 2 years
Immacolata Maietta
Matched on ORCID iD 0000-0002-0700-6013; OpenAlex author ID A5085878517. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 4
2022: 1 paper · 2023: none · 2024: none · 2025: 2 papers · 2026: 1 paper
Papers 4
- CLDN18 as a novel junctional biomarker enhancing multi-gene classification of pancreatic cancer. Last author DOI 10.1016/j.tranon.2026.102993↗
- Harnessing epigenetic inhibitors: A promising approach for overcoming challenges in pancreatic ductal adenocarcinoma treatment. Co-author DOI 10.1016/j.addr.2025.115638↗
- Sequential YAP1/FOSL1 silencing and epigenetic therapy to overcome stromal barriers in pancreatic cancer. Co-author DOI 10.1016/j.ijpharm.2025.126155↗
- Synergistic Antitumoral Effect of Epigenetic Inhibitors and Gemcitabine in Pancreatic Cancer Cells. Co-author DOI 10.3390/ph15070824↗
Closest collaborators
The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- África González‐Fernández · 4 shared papers, 2022–2026 · strength 1.15
- Paper Harnessing epigenetic inhibitors: A promising approach for overcoming challenges in pancreatic ductal adenocarcinoma tr… DOI 10.1016/j.addr.2025.115638↗
- Paper CLDN18 as a novel junctional biomarker enhancing multi-gene classification of pancreatic cancer. DOI 10.1016/j.tranon.2026.102993↗
- Paper Sequential YAP1/FOSL1 silencing and epigenetic therapy to overcome stromal barriers in pancreatic cancer. DOI 10.1016/j.ijpharm.2025.126155↗
- Rosana Simón‐Vázquez · 3 shared papers, 2022–2025 · strength 0.88
- Paper Harnessing epigenetic inhibitors: A promising approach for overcoming challenges in pancreatic ductal adenocarcinoma tr… DOI 10.1016/j.addr.2025.115638↗
- Paper Sequential YAP1/FOSL1 silencing and epigenetic therapy to overcome stromal barriers in pancreatic cancer. DOI 10.1016/j.ijpharm.2025.126155↗
- Paper Synergistic Antitumoral Effect of Epigenetic Inhibitors and Gemcitabine in Pancreatic Cancer Cells. DOI 10.3390/ph15070824↗
- Jessie Santoro · 1 shared paper, 2026 · strength 0.27
- Amparo Martínez-Pérez · 1 shared paper, 2022 · strength 0.19
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.